Association of cytolethal distending toxin-II gene-positive Escherichia coli with Escherichia albertii , an emerging enteropathogen

Abbott, 2003, Biochemical properties of a newly described Escherichia species, Escherichia albertii, J. Clin. Microbiol., 41, 4852, 10.1128/JCM.41.10.4852-4854.2003 Albert, 1991, Hafnia alvei, a probable cause of diarrhea in humans, Infect. Immun., 59, 1507, 10.1128/IAI.59.4.1507-1513.1991 Albert, 1992, Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alvei, J. Med. Microbiol., 37, 310, 10.1099/00222615-37-5-310 Asoshima, 2014, Identification of Escherichia albertii as a causative agent of a food-borne outbreak occurred in Japan, Jpn. J. Infect. Dis., 67, 139, 10.7883/yoken.67.139 Brandel, 2015, Shiga toxin 2a in Escherichia albertii, J. Clin. Microbiol., 53, 1454, 10.1128/JCM.03378-14 Buvens, 2012, Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010, J. Clin. Microbiol., 50, 1336, 10.1128/JCM.05317-11 Ewing, 1986, The genus Escherichia, 93 Farmer, 1999, Enterobacteriaceae: introduction and identification, 442 Fox, 2004, Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains, Infect. Immun., 72, 1116, 10.1128/IAI.72.2.1116-1125.2004 Friesema, 2014, Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in the Netherlands, January 2008 to December 2011, Euro Surveill., 19, 26, 10.2807/1560-7917.ES2014.19.17.20787 Friesema, 2015, Hemolytic uremic syndrome associated with Escherichia coli O8:H19 and Shiga toxin 2f gene, Emerg. Infect. Dis., 21, 168, 10.3201/eid2101.140515 Ge, 2005, Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice, Infect. Immun., 73, 3559, 10.1128/IAI.73.6.3559-3567.2005 Ge, 2007, Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis, Cell. Microbiol., 9, 2070, 10.1111/j.1462-5822.2007.00939.x Hinenoya, 2009, Prevalence and characteristics of cytolethal distending toxin-producing Escherichia coli from children with diarrhea in Japan, Microbiol. Immunol., 53, 206, 10.1111/j.1348-0421.2009.00116.x Hinenoya, 2014, Molecular characterization of cytolethal distending toxin gene-positive Escherichia coli from healthy cattle and swine in Nara, Japan, BMC Microbiol., 14, 97, 10.1186/1471-2180-14-97 Hinenoya, 2017, Isolation and characterization of an Escherichia albertii producing three different toxins isolated from a child with diarrhea, Jpn. J. Infect. Dis., 70, 252, 10.7883/yoken.JJID.2016.186 Huys, 2003, Escherichia albertii sp. Nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children, Int. J. Syst. Evol. Microbiol., 53, 807, 10.1099/ijs.0.02475-0 Hyma, 2005, Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains, J. Bacteriol., 187, 619, 10.1128/JB.187.2.619-628.2005 Janka, 2003, Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations, Infect. Immun., 71, 3634, 10.1128/IAI.71.6.3634-3638.2003 Johnson, 1987, Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin, FEMS Microbiol. Lett., 43, 19, 10.1111/j.1574-6968.1987.tb02091.x Lara-Tejero, 2001, CdtA, CdtB and CdtC form a tripartite complex that is required for cytolethal distending toxin activity, Infect. Immun., 69, 4358, 10.1128/IAI.69.7.4358-4365.2001 Lee, 2003, Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells, Infect. Immun., 71, 4883, 10.1128/IAI.71.9.4883-4890.2003 McAuley, 2007, MUC1 cell surface mucin is a critical element of the mucosal barrier to infection, J. Clin. Invest., 117, 2313, 10.1172/JCI26705 Murakami, 2014, Shiga toxin 2f-producing Escherichia albertii from a symptomatic human, Jpn. J. Infect. Dis., 67, 204, 10.7883/yoken.67.204 National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare, 2016, vol. 37, 98 Oaks, 2010, Escherichia albertii in wild and domestic birds, Emerg. Infect. Dis., 16, 638, 10.3201/eid1604.090695 Ooka, 2012, Clinical significance of Escherichia albertii, Emerg. Infect. Dis., 18, 488, 10.3201/eid1803.111401 Ooka, 2013, Human gastroenteritis outbreak associated with Escherichia albertii, Japan, Emerg. Infect. Dis., 19, 144, 10.3201/eid1901.120646 Ooka, 2015, Defining the genome features of Escherichia albertii, an emerging enteropathogen closely related to Escherichia coli, Genome Biol. Evol., 7, 3170 Pérès, 1997, A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase, Mol. Microbiol., 24, 1095, 10.1046/j.1365-2958.1997.4181785.x Paton, 1998, Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections, Clin. Microbiol Rev., 11, 450, 10.1128/CMR.11.3.450 Pickett, 1994, Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes, Infect. Immun., 62, 1046, 10.1128/IAI.62.3.1046-1051.1994 Scott, 1994, Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin, Infect. Immun., 62, 244, 10.1128/IAI.62.1.244-251.1994 Shima, 2012, Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea, Infect. Immun., 80, 1323, 10.1128/IAI.05831-11 Tóth, 2003, Production of cytolethal distending toxin by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (Type IV), J. Clin. Micriobiol., 41, 4285, 10.1128/JCM.41.9.4285-4291.2003 Tsukamoto, 1992, Enteroadherent Escherichia coli exhibiting localized pattern of adherence among infants with diarrhoea in Brazil -incidence and prevalence of serotypes-, J. Jpn. Assoc. Infect. Dis., 66, 1538 Wilson, 1987, Preparation of genomic DNA from bacteria, 2.4.1 Wirth, 2006, Sex and virulence in Escherichia coli: an evolutionary perspective, Mol. Microbiol., 60, 1136, 10.1111/j.1365-2958.2006.05172.x Yamasaki, 2006, Cytolethal distending toxin (CDT): genetic diversity, structure and role in diarrheal disease, Toxin Rev., 25, 61, 10.1080/15569540500320938 Young, 2004, In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants, Infect. Immun., 72, 2521, 10.1128/IAI.72.5.2521-2527.2004